Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury CP Andrews, JJ Coalson, JD Smith, WG Johanson Chest 80 (3), 254-258, 1981 | 648 | 1981 |
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease SI Rennard, C Fogarty, S Kelsen, W Long, J Ramsdell, J Allison, D Mahler, ... American journal of respiratory and critical care medicine 175 (9), 926-934, 2007 | 530 | 2007 |
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial M Selim, LD Foster, CS Moy, G Xi, MD Hill, LB Morgenstern, ... The Lancet Neurology 18 (5), 428-438, 2019 | 191 | 2019 |
Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older AL Cunningham, TC Heineman, H Lal, O Godeaux, R Chlibek, SJ Hwang, ... The Journal of infectious diseases 217 (11), 1750-1760, 2018 | 154 | 2018 |
Guidelines as to what constitutes an adverse respiratory health effect, with special reference to epidemiologic studies of air pollution C Andrews, S Buist, BG Ferris American Review of respiratory disease 131 (4), 666-668, 1985 | 116 | 1985 |
Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergillomas CP Andrews, MH Weiner The American journal of medicine 73 (3), 372-380, 1982 | 115 | 1982 |
Allergen exposure chambers: harmonizing current concepts and projecting needs for the future-an EAACI position paper O Pfarr, MA Calderone, CP Andrews, E Angieli, et al Allergy 72, 1035-1042, 0 | 114* | |
Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial DP Tashkin, M Littner, CP Andrews, LT Tomlinson, M Rinehart, ... Respiratory medicine 102 (4), 479-487, 2008 | 113 | 2008 |
Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome JI Peters, RC Bell, TJ Prihoda, G Harris, C Andrews, WG Johanson Am Rev Respir Dis 139 (5), 1163-1168, 1989 | 102 | 1989 |
Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. BG Martin, PH Ratner, FC Hampel, CP Andrews, T Toler, W Wu, MA Faris, ... Allergy & Asthma Proceedings 28 (2), 2007 | 97 | 2007 |
Six-month safety data of recombinant vesicular stomatitis virus–Zaire Ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebo-controlled randomized study … SA Halperin, JR Arribas, R Rupp, CP Andrews, L Chu, R Das, JK Simon, ... The Journal of infectious diseases 215 (12), 1789-1798, 2017 | 90 | 2017 |
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with … M Zervos, LA Mandell, PS Vrooman, CP Andrews, A McIvor, RH Abdulla, ... Treatments in respiratory medicine 3, 329-336, 2004 | 81 | 2004 |
The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 clinical trials ZOE … C Boutry, A Hastie, J Diez-Domingo, JC Tinoco, CJ Yu, C Andrews, ... Clinical Infectious Diseases 74 (8), 1459-1467, 2022 | 75 | 2022 |
Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes RL Jacobs, N Harper, W He, CP Andrews, CG Rather, DA Ramirez, ... Journal of allergy and clinical immunology 130 (1), 122-127. e8, 2012 | 66 | 2012 |
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms BG Martin, CP Andrews, JH van Bavel, FC Hampel, KC Klein, ... Annals of Allergy, Asthma & Immunology 96 (6), 851-857, 2006 | 66 | 2006 |
Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase 1/2 randomized clinical trial I Leroux-Roels, MG Davis, K Steenackers, B Essink, C Vandermeulen, ... The Journal of Infectious Diseases 227 (6), 761-772, 2023 | 55 | 2023 |
Hypersensitivity pneumonitis: beyond classic occupational disease–changing concepts of diagnosis and management RL Jacobs, CP Andrews, JJ Coalson Annals of Allergy, Asthma & Immunology 95 (2), 115-128, 2005 | 52 | 2005 |
Organic antigen-induced interstitial lung disease: diagnosis and management RL Jacobs, CP Andrews, J Coalson Annals of Allergy, Asthma & Immunology 88 (1), 30-41, 2002 | 49 | 2002 |
Immunodiagnosis of invasive pulmonary aspergillosis in rabbits: fungal antigen detected by radioimmunoassay in bronchoalveolar lavage fluid CP Andrews, MH Weiner American Review of Respiratory Disease 124 (1), 60-64, 1981 | 49 | 1981 |
Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis CP Andrews, D Mohar, Y Salhi, SK Tantry Annals of Allergy, Asthma & Immunology 124 (2), 171-178. e2, 2020 | 48 | 2020 |